Werewolf Therapeutics, Inc. - Common Stock (HOWL)

CUSIP: 95075A107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock
Shares outstanding
47,916,629
Total 13F shares
32,251,087
Share change
+4,581,388
Total reported value
$208,968,732
Put/Call ratio
1458%
Price per share
$6.48
Number of holders
59
Value change
+$29,830,206
Number of buys
38
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 95075A107?
CUSIP 95075A107 identifies HOWL - Werewolf Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q1 2024

As of 31 Mar 2024, Werewolf Therapeutics, Inc. - Common Stock (HOWL) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,251,087 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, PFM Health Sciences, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., MPM BIOIMPACT LLC, BANK OF AMERICA CORP /DE/, JANUS HENDERSON GROUP PLC, Rubric Capital Management LP, VANGUARD GROUP INC, and Monashee Investment Management LLC. This page lists 59 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.